vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Outdoor Holding Co (POWW). Click either name above to swap in a different company.
Outdoor Holding Co is the larger business by last-quarter revenue ($13.4M vs $9.2M, roughly 1.4× Foghorn Therapeutics Inc.). Outdoor Holding Co runs the higher net margin — 16.7% vs -234.3%, a 250.9% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -54.1%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.
FHTX vs POWW — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $13.4M |
| Net Profit | $-21.7M | $2.2M |
| Gross Margin | — | 87.1% |
| Operating Margin | -258.2% | 14.7% |
| Net Margin | -234.3% | 16.7% |
| Revenue YoY | 223.8% | -54.1% |
| Net Profit YoY | -11.1% | 108.5% |
| EPS (diluted) | $-0.35 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $13.4M | ||
| Q3 25 | $8.2M | $12.0M | ||
| Q2 25 | $7.6M | $11.9M | ||
| Q1 25 | $6.0M | $12.6M | ||
| Q4 24 | $2.9M | $12.5M | ||
| Q3 24 | $7.8M | $12.0M | ||
| Q2 24 | $6.9M | $12.3M | ||
| Q1 24 | $5.0M | $-50.7M |
| Q4 25 | $-21.7M | $2.2M | ||
| Q3 25 | $-15.8M | $1.4M | ||
| Q2 25 | $-17.9M | $-6.5M | ||
| Q1 25 | $-18.8M | $-77.5M | ||
| Q4 24 | $-19.5M | $-26.1M | ||
| Q3 24 | $-19.1M | $-12.4M | ||
| Q2 24 | $-23.0M | $-14.8M | ||
| Q1 24 | $-25.0M | $-5.2M |
| Q4 25 | — | 87.1% | ||
| Q3 25 | — | 87.1% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 87.5% | ||
| Q4 24 | — | 87.4% | ||
| Q3 24 | — | 86.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | — |
| Q4 25 | -258.2% | 14.7% | ||
| Q3 25 | -226.9% | 5.9% | ||
| Q2 25 | -279.2% | -50.7% | ||
| Q1 25 | -385.0% | -213.6% | ||
| Q4 24 | -840.5% | -163.8% | ||
| Q3 24 | -305.5% | -50.3% | ||
| Q2 24 | -386.6% | -50.8% | ||
| Q1 24 | -558.3% | — |
| Q4 25 | -234.3% | 16.7% | ||
| Q3 25 | -194.4% | 11.7% | ||
| Q2 25 | -237.3% | -54.5% | ||
| Q1 25 | -316.4% | -614.5% | ||
| Q4 24 | -682.9% | -208.7% | ||
| Q3 24 | -244.9% | -103.7% | ||
| Q2 24 | -333.6% | -120.2% | ||
| Q1 24 | -495.4% | 10.3% |
| Q4 25 | $-0.35 | $0.01 | ||
| Q3 25 | $-0.25 | $0.01 | ||
| Q2 25 | $-0.28 | $-0.06 | ||
| Q1 25 | $-0.30 | $-0.67 | ||
| Q4 24 | $-0.23 | $-0.23 | ||
| Q3 24 | $-0.31 | $-0.11 | ||
| Q2 24 | $-0.45 | $-0.13 | ||
| Q1 24 | $-0.59 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $69.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $237.3M |
| Total Assets | $198.1M | $271.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $69.9M | ||
| Q3 25 | $89.3M | $65.7M | ||
| Q2 25 | $72.6M | $63.4M | ||
| Q1 25 | $61.0M | $30.2M | ||
| Q4 24 | $55.5M | $31.9M | ||
| Q3 24 | $57.7M | $33.5M | ||
| Q2 24 | $138.9M | $50.8M | ||
| Q1 24 | $79.3M | $55.6M |
| Q4 25 | $-108.5M | $237.3M | ||
| Q3 25 | $-89.7M | $235.4M | ||
| Q2 25 | $-76.7M | $222.5M | ||
| Q1 25 | $-61.7M | $222.0M | ||
| Q4 24 | $-45.5M | $299.6M | ||
| Q3 24 | $-28.3M | $325.6M | ||
| Q2 24 | $-14.3M | $342.5M | ||
| Q1 24 | $-97.5M | $358.0M |
| Q4 25 | $198.1M | $271.7M | ||
| Q3 25 | $205.0M | $270.3M | ||
| Q2 25 | $226.2M | $269.5M | ||
| Q1 25 | $258.7M | $297.3M | ||
| Q4 24 | $284.0M | $355.4M | ||
| Q3 24 | $308.4M | $368.9M | ||
| Q2 24 | $328.6M | $398.6M | ||
| Q1 24 | $255.0M | $403.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $5.7M |
| Free Cash FlowOCF − Capex | — | $5.0M |
| FCF MarginFCF / Revenue | — | 37.6% |
| Capex IntensityCapex / Revenue | 0.0% | 4.8% |
| Cash ConversionOCF / Net Profit | — | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $5.7M | ||
| Q3 25 | $-18.9M | $3.2M | ||
| Q2 25 | $-21.0M | $-6.7M | ||
| Q1 25 | $-24.0M | $-1.5M | ||
| Q4 24 | $-24.5M | $1.3M | ||
| Q3 24 | $-21.0M | $-9.3M | ||
| Q2 24 | $-25.5M | $-547.5K | ||
| Q1 24 | $-29.3M | $4.3M |
| Q4 25 | — | $5.0M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | $-21.0M | $-7.6M | ||
| Q1 25 | $-24.0M | $-2.3M | ||
| Q4 24 | $-25.0M | $720.3K | ||
| Q3 24 | $-21.3M | $-10.6M | ||
| Q2 24 | $-25.6M | $-1.3M | ||
| Q1 24 | $-29.4M | $1.4M |
| Q4 25 | — | 37.6% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | -278.2% | -63.8% | ||
| Q1 25 | -403.2% | -18.6% | ||
| Q4 24 | -875.3% | 5.8% | ||
| Q3 24 | -273.0% | -88.3% | ||
| Q2 24 | -371.0% | -11.0% | ||
| Q1 24 | -583.1% | -2.8% |
| Q4 25 | 0.0% | 4.8% | ||
| Q3 25 | 0.0% | 5.8% | ||
| Q2 25 | 0.3% | 7.5% | ||
| Q1 25 | 0.5% | 6.5% | ||
| Q4 24 | 16.8% | 4.4% | ||
| Q3 24 | 4.0% | 10.4% | ||
| Q2 24 | 0.2% | 6.5% | ||
| Q1 24 | 2.0% | -5.7% |
| Q4 25 | — | 2.55× | ||
| Q3 25 | — | 2.29× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
